A Kazda
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A Kazda.
Critical Care | 2009
Helena Brodska; Tomas Drabek; Karin Malickova; A Kazda; Antonin Vitek; Tomáš Zima; Marketa Markova
IntroductionProcalcitonin (PCT) and C-reactive protein (CRP) are established markers of infection in the general population. In contrast, several studies reported falsely increased PCT levels in patients receiving T-cell antibodies. We evaluated the validity of these markers in patients scheduled for hemopoietic stem cell transplantation receiving anti-thymocyte globulin (ATG) during conditioning. We also assessed renal and liver functions and their relationship to PCT and CRP changes.MethodsTwenty-six patients without clinical signs of infection were prospectively studied. ATG was administered in up to three doses over the course of 5 days. PCT, CRP, white blood cell (WBC) count, urea, creatinine, glomerular filtration rate, bilirubin, alanin amino-transferase (ALT), and gamma-glutamyl transferase (GGT) were assessed daily during ATG administration. Pharyngeal, nose, and rectal swabs and urine samples were cultured twice weekly. Blood cultures were obtained if clinical symptoms of infection were present.ResultsBaseline (BL) levels of both PCT and CRP before ATG administration were normal. WBC count decreased after ATG administration (P = 0.005). One day after ATG administration, both PCT and CRP levels increased significantly, returning to BL levels on day 4. Microbiological results were clinically unremarkable. There was no interrelationship between PCT levels and BL markers of renal or liver functions (P > 0.05 for all comparisons). Bilirubin and GGT were increased on days 2 to 5 and ALT was increased on day 3 (P < 0.05 versus BL). No difference in renal functions was observed. Three patients developed bacterial infection on days 7 to 11 with different dynamics of PCT and CRP. There was no association between the number of ATG doses and PCT levels or between the risk of developing infection and previous PCT levels.ConclusionsATG triggered a marked early surge in PCT and CRP followed by a steady decrease over the course of 3 days. The dynamics of both PCT and CRP were similar and were not associated with infection. PCT levels were independent of renal and liver functions and were not predictive of further infectious complications. A direct effect of ATG on T lymphocytes could be the underlying mechanism. Hepatotoxic effect could be a contributing factor. Neither PCT nor CRP is a useful marker that can identify infection in patients receiving ATG.
Intensive Care Medicine | 2011
Jiri Valenta; Helena Brodska; Tomas Drabek; Jan Hendl; A Kazda
Critical Care | 2007
Jiri Valenta; Helena Brodska; A Kazda; Zdenek Stach; Jan Hendl; K Pelinkova
Critical Care | 2006
A Kazda; Helena Brodska; Jiri Valenta; M Vinglerová; Jan Hendl; Zdenek Stach; I Slabá
Trace Elements and Electrolytes | 2012
Jiri Valenta; Helena Brodska; Tomas Drabek; Zdenek Stach; Tomáš Zima; A Kazda
Critical Care | 2008
Helena Brodska; Karin Malickova; A Kazda; J Lachmanova; J Uhrova; Tomáš Zima
Critical Care | 2011
V Spatenkova; A Kazda; P Suchomel
Critical Care | 2010
V Spatenkova; A Kazda; P Suchomel
Critical Care | 2009
V Spatenkova; A Kazda; P Suchomel
Critical Care | 2008
V Spatenkova; A Kazda; P Skrabalek; P Suchomel